0

Neonatal estrogen stimulation nd aggressive behavior in female mice

Edwards DA et al., 1970

Physiology & Behavior, 5(9), 993-995

DOI 10.1016/0031-9384(70)90153-8

Abstract

No abstract available for this article.

Topics

PCOS > Metabolic Effects > CardiovascularPCOS > Pathophysiology > Insulin ResistancePCOS > Treatment > Lifestyle
metabolic syndrome in polycystic ovary syndrome, PCOS cardiometabolic risk screening, insulin resistance cardiovascular risk PCOS, lifestyle modification metabolic syndrome PCOS, central obesity hypertension PCOS, type 2 diabetes risk polycystic ovary syndrome, dyslipidemia in women with PCOS, long-term health consequences PCOS

Cite this article

Edwards DA, Herndon J (1970). Neonatal estrogen stimulation nd aggressive behavior in female mice. *Physiology & Behavior*, *5*(9), 993-995. https://doi.org/10.1016/0031-9384(70)90153-8

Keywords

Aggression/drug Effects, Animals, Animals, Newborn, Behavior, Animal/drug Effects, Benzoates, Castration, Estradiol/pharmacology, Female, Humans, Mice, Oils, Propionates, Sex Factors, Testosterone/pharmacology, Benzoates, Oils, Propionates, Testosterone, Estradiol,

Related articles

Chapter 43: Polycystic Ovarian Disease
Hilgers TW, 2004 The Medical and Surgical Practice of NaProTECHNOLOGY
PCOS > Diagnosis > Rotterdam CriteriaPCOS > Diagnosis > PhenotypesPCOS > Pathophysiology > Insulin Resistance

Polycystic ovary syndrome: it's not just infertility
Hunter MH et al., 2000 American Family Physician

Recent diagnostic and pharmacologic developments have focused renewed attention on polycystic ovary syndrome. Clinical features of the syndrome include anovulation, hyperandrogenism and menstrual dysf...

PCOS > Pathophysiology > Insulin ResistancePCOS > Diagnosis > Rotterdam CriteriaPCOS > Metabolic Effects > Cardiovascular

[Polycystic ovary syndrome--only relevant in reproductive medicine?]
Heim SC et al., 1999 Therapeutische Umschau. Revue Therapeutique

The Polycystic Ovary Disease (PCOD) is one of the most common endocrine disorders in women with a prevalence of 5%. Affected women often consult a gynecologist because of menstrual irregularities, fer...

PCOS > Pathophysiology > Insulin ResistancePCOS > Treatment > LifestylePCOS > Metabolic Effects > Cardiovascular

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women
Dahlgren E et al., 1992 Acta Obstetricia Et Gynecologica Scandinavica

In order to estimate whether women with polycystic ovary syndrome (PCOS) have an increased risk of developing myocardial infarction, a risk factor model was applied on 33 women with PCOS and 132 age m...

PCOS > Metabolic Effects > CardiovascularPCOS > Pathophysiology > Insulin ResistancePCOS > Treatment > Lifestyle